Dr. Nathalie Grandvaux
- • RESPONSABLE DE L’AXE IMMUNOPATHOLOGIE & CHERCHEUSE RÉGULIERE, CENTRE DE RECHERCHE DU CHUM• PROFESSOR, DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR MEDICINE, UNIVERSITÉ DE MONTRÉAL• PRESIDENT OF THE CANADIAN SOCIETY FOR VIROLOGY
Nathalie Grandvaux est professeure titulaire au département de biochimie et de médecine moléculaire de l’Université de Montréal (UdeM) et chercheure principale au Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) depuis 2005.
With a biochemical perspective, her research program focuses on understanding the molecular mechanisms that control host-virus interactions. Her group has notably made seminal discoveries of host proteins that allow appropriate regulation in the intensity and duration of antiviral and proinflammatory responses needed to resolve respiratory viral infections, particularly by RNA viruses. The ultimate goal of this research is to develop host-targeted briad spectrum antivirals. Her research on the interferon-mediated antiviral response also finds applications in the understanding of autoimmune and chronic inflammatory diseases, such as interferonopathies.
She has co-authored 66 peer-reviewed publications in internationally renowned journals and is regularly invited to give lecture in research institutions in Canada and abroad. She is a frequent peer reviewer and scientific officer in grant programs for various Canadian and international organizations and a member of several advisory committees.
In 2016, she co-founded the Canadian Society for Virology (CSV), a not-for-profit organization intended to promote the advancement of education, dissemination and application of knowledge related to Virology. She is now the elected president (2019-2020) of CSV which has around 200 members across Canada. She has contributed to the organization of several national and international conferences.